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Executive Summary
The Kentucky Department of Public Health is responsible for improving the health and safety of
Kentucky’s residents by preventing disease and injuries and encouraging healthy lifestyles. The
department administers nearly 150 programs that address critical health issues affecting
Kentuckians. These programs screen newborns for health problems, prevent the spread of
infectious diseases, promote oral health, and provide numerous other services.
Diabetes represents a growing health concern for the nation and Kentucky. It is a chronic
condition that causes blood sugar levels to rise and contributes to other serious health conditions
such as heart and kidney disease. The U.S. Centers for Disease Control and Prevention lists
diabetes as the 7th leading cause of death in the nation.
The disease imposes significant costs on the country’s economy. The American Diabetes
Association estimates that the U.S. spends $237 billion annually on diabetes-related health care.
In addition, diabetes also adversely affects the nation’s workforce. As the disease progresses,
individuals may find it more difficult to work. This can reduce employment, productivity, wages,
and tax revenue.
To better understand how diabetes affects Kentucky residents, the Kentucky Department of
Public Health contracted with the University of Kentucky’s Center for Business and Economic
Research to study the economic impacts of the disease. This study has three main goals:
1. estimate the effect diabetes has on Kentucky’s workforce;
2. estimate the short-run and long-run effects diabetes has on state tax revenues; and
3. examine how prevention and education programs could affect the health of those with
diabetes and how they could potentially affect the state’s workforce and tax revenues.
Nationally, 10.9 percent of adults have been diagnosed with diabetes, but the incidence rate for
the disease in Kentucky is higher. The percentage of Kentucky adults diagnosed with diabetes
has increased from 9.9 percent in 2007 to 12.8 percent in 2017. Currently, approximately
441,000 Kentucky adults have diabetes. The disease is more common among older adults,
African Americans, and individuals with less education.
Past research shows that diabetes is associated with lower employment and earnings. In
Kentucky, diabetes reduces employment by approximately 15,700 workers. This represents a
loss of $551.3 million in earnings and $33.1 million in state tax revenue annually.
Diabetes contributed to 473 deaths of Kentucky residents between the ages of 35 and 64 in 2016.
In the absence of the disease, many of these individuals would have worked and earned wages.
These deaths represent lost earnings of $12 million and lost state tax revenue of $710,000 during
the first year after death.
Note that this estimate only represents the losses for deaths that occurred in a single year, 2016.
The total earnings and tax revenues lost to diabetes in any given calendar year would actually be
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larger than the result of a single-year’s deaths, once the cumulative effects of losses associated
with those who have died over the preceding years are also factored in.
The present value of lifetime lost earnings and revenues for the 473 Kentucky residents who died
due to diabetes in 2016 total $100.4 million and $6.02 million, respectively.
The American Diabetes Association estimates that those with diabetes incur $5,000 to $12,300 in
additional health care costs relative to those without diabetes per year. These estimates suggest
that diabetes contributes to an additional $3.9 billion in health care costs in Kentucky annually.
Lifestyle intervention programs help individuals who have a high risk of developing diabetes
lose weight through healthier lifestyles. Evaluations of these programs show that they can reduce
the long-term incidence of diabetes. Although these programs do not appear to reduce total
health care costs relative to typical treatment for diabetes, research shows that lifestyle
interventions can be cost-effective ways to improve the quality of life for participants.
Lifestyle intervention programs may also improve employment and earnings. Because lifestyle
interventions reduce the incidence of developing diabetes, they might also increase the
percentage of people who are able to work and earn a living. However, it is unlikely that lifestyle
interventions would increase tax revenues by enough to cover the costs of the program. For
example, an average 45-year-old male who participates in the program could expect to earn
approximately $12,600 in additional income and generate $756 in additional state tax revenue
over his lifetime, when compared to a male of the same age with diabetes who does not
participate in an intervention program. While this amount would not cover the cost of the
program, it would help offset a portion of these costs.
Diabetes education programs are designed to help those with diabetes manage their disease. Past
research has shown that these programs can provide meaningful improvements in weight, blood
sugar levels, and blood pressure. Researchers have generally found that they appear to be costeffective, but estimates vary. There appears to be little meaningful research on whether education
programs improve labor market outcomes.
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Section 1: Introduction
Diabetes is a chronic health condition that limits the body’s ability to turn food into energy. This
occurs either because the pancreas does not produce insulin, or the body is unable to use the
insulin produced. As a result, blood sugar levels rise and contribute to other serious health
conditions such as heart and kidney disease.
The U.S. Centers for Disease Control (CDC) estimates that the number of people in the U.S. who
suffer from diabetes has grown by 300 percent in the past 20 years and now stands at over 30
million. Twenty-five percent of these individuals do not yet realize they have the disease. An
additional 84 million adults in the U.S. have prediabetes.
The cost associated with diabetes creates a significant burden on the national economy. Health
care costs of diabetes alone has been estimated at $237 billion annually (American Diabetes
Association 2018). In 2016, diabetes contributed to over 80,000 deaths in the U.S., making it the
nation’s 7th leading cause of death (CDC, Leading Causes of Death).
Diabetes also creates an economic burden by reducing employment and earnings. As their health
declines, individuals suffering from diabetes may be less likely to work, earn lower wages, and
incur higher rates of absenteeism. The American Diabetes Association estimates that lost
earnings associated with diabetes in the U.S. totaled $90 billion in 2017.
These adverse economic effects have implications for state and local policy makers as they
consider whether to adopt policies to address diabetes. Not only does diabetes increase the costs
for state and local assistance programs such as Medicaid, but it also affects labor market
outcomes. These effects can in turn reduce state and local tax revenues. By increasing
expenditures and decreasing revenues, diabetes can have significant fiscal implications for state
and local governments.
In July 2018, the Kentucky Department of Public Health contracted with the University of
Kentucky’s Center for Business and Economic Research (CBER) to examine how the prevalence
of diabetes in Kentucky affects the Commonwealth’s labor market. This study has three specific
objectives:
1. estimate the effect diabetes has on Kentucky’s workforce;
2. estimate the short-run and long-run effects diabetes has on state tax revenues; and
3. examine how prevention and education programs could affect the health of those with
diabetes and how they could potentially affect the state’s workforce and tax revenues.

Section 2: Prevalence of Diabetes in Kentucky
Data from the CDC shows that diabetes is more common in Kentucky than the nation.
Approximately 12.8 percent of Kentucky adults, or 441,000 individuals, have been diagnosed
with diabetes. This compares to 10.9 percent in the U.S. While diabetes occurs among the entire
population, it tends to be more prevalent among certain demographic groups. This section
examines trends in the prevalence of diabetes in Kentucky over time and across these
1

Center for Business and Economic Research
Gatton College of Business and Economics

University of Kentucky

demographic groups. The figures below focus on the adult population and exclude cases of
diabetes that are related to pregnancies or are undiagnosed. The data for this analysis comes from
the U.S. CDC’s Behavioral Risk Factor Surveillance System (BRFSS).
Figure A shows that the share of the population with diabetes has been growing for both
Kentucky and the U.S. In 2007, only 9.9 percent of Kentucky adults were diagnosed with
diabetes. This rate grew to 12.8 percent by 2017. The CDC cites the aging of the population and
increasing obesity rates as factors contributing to this growth.
Figure A
Prevalence of Diabetes among Adult Population
US and Kentucky
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Source: CBER analysis of data from the Kentucky Department of Public Health and the United
States Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System
2007 to 2017.
Note: Excludes diabetes related to pregnancies.
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Diabetes has generally been equally prevalent among males and females. Figure B shows that the
rate of diabetes has grown for both groups.
Figure B
Prevalence of Diabetes Among Adults by Gender
Kentucky
16
14

Percent
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10
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Males

6

Females

4
2
0
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Source: CBER analysis of data from the Kentucky Department of Public Health and the United
States Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System
2007 to 2017.
Note: Excludes diabetes related to pregnancies.

Diabetes becomes more prevalent later in life (Figure C). In Kentucky, approximately 14 percent
of those aged 45 to 54 had diabetes, while roughly 22 percent of those aged 60 to 64 reported
having diabetes. There was little difference between the U.S. and Kentucky in prevalence among
those under the age of 45. Type 1 diabetes is usually diagnosed at an early age, while type 2
diabetes develops later in life and is often associated with lifestyle choices such as diet and
physical activity. Approximately 90 percent of diabetes cases are type 2 (U.S. Centers for
Disease Control and Prevention).
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Figure C
Prevalence of Diabetes by Age
US and Kentucky
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Source: CBER analysis of data from the Kentucky Department of Public Health and the United
States Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System
2017.
Note: Excludes diabetes related to pregnancy.

Nationally, diabetes is more common among African Americans than Whites and other racial
groups (Figure D). However, there is little difference in the prevalence of diabetes among
African Americans and Whites in Kentucky.
Figure D
Prevalence of Diabetes by Race
US and Kentucky
15
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Source: CBER analysis of data from the Kentucky Department of Public Health and the United
States Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System
2017.
Note: Excludes diabetes related to pregnancy.
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Diabetes is more common among individuals with less education (Figure E). In Kentucky, adults
not completing high school are more than twice as likely to suffer from diabetes compared to
those with a college education.
Figure E
Prevalence of Diabetes by Education
US and Kentucky
25
US

Kentucky

Percent
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Source: CBER analysis of data from the Kentucky Department of Public Health and the United States
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2017.
Note: Excludes diabetes related to pregnancy.

Section 3: Employment and Earnings
Diabetes has been associated with reduced employment, earnings, and productivity. This section
reviews past research examining these relationships and estimates the impact that diabetes has on
Kentucky’s labor market and state tax revenues.
Past Research
The negative labor market effects associated with diabetes may begin at an early age. Fletcher
and Richards (2012) followed a group of adolescents from 1995 through 2008 to examine how
diabetes affected their educational attainment. After controlling for other health conditions and
family illnesses, they found that those with diabetes were six percentage points more likely to
drop out of school; completed 0.254 fewer years of education; and were nearly eight percentage
points less likely to attend college. These lower educational outcomes contributed to reductions
in employment and earnings later in life.
Numerous studies have examined the relationship between diabetes and employment. While the
studies generally found that diabetes was associated with lower employment, the magnitudes of
the association varied considerably. Most estimates suggested that those with diabetes are three
to 10 percentage points less likely to be employed (Seuring et al. 2015). However, some studies
found no statistically significant effects for certain groups of the population, and one found a 455
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percentage-point decrease in the likelihood of employment (Bastida 2002; Brown et al. 2005;
Minor 2011). Some of the differences in these results occur because these studies focused on
different population groups and used different statistical methods to estimate the effects (Seuring
et al. 2015).
The negative impacts appear to be stronger for older individuals. Tunceli et al. (2009) provides a
good example of this difference. Between the ages of 20 and 44, those with diabetes were 1.2
percentage points more likely to be disabled; 3.1 percentage points more likely to report having
health related work limitations; and 3.4 percentage points more likely to not work. The effects
were considerably larger for those with diabetes between the ages of 45 to 64, who were 3.4
percentage points more likely to be disabled; 5.7 percentage points more likely to report having
health related work limitations; and 8.1 percentage points more likely to not work. The larger
effects for older workers is likely due to the progressive nature of the disease (Minor 2013).
Diabetes also appears to reduce days and hours worked. The research is less clear on this issue,
and the effects appear to differ by gender and the type of diabetes. Vijan et al. (2004) and
Valdmanis and Page (2001) estimated that those with diabetes worked 2.4 and 3.9 fewer days per
year, respectively. Tuncelli et al. (2005) found that diabetes was associated with a reduction in
days worked for men but not women. Minor (2011) found that those with type 1 diabetes worked
on average 3.3 fewer days in the past year than those without diabetes, but they found no
evidence that those with type 2 diabetes worked fewer days. Ng et al. (2001) found days worked
decreased when complications related to diabetes arose. However, Collins et al. (2005) found no
difference in the number of days worked. Minor and MacEwan (2016) presented evidence to
suggest that the main adverse effect may come from reductions in hours worked. They found that
men with type 2 diabetes worked seven fewer hours per week and women with type 2 diabetes
worked eight fewer hours.
If diabetes causes workers to be less productive—by reducing the time they spend working,
limiting their investments in education, or through some other mechanism—then diabetes may
also reduce their wages and earnings. Valdmanis et al. (2001), Bastida (2002), Brown et al.
(2011), and Minor (2011) all present evidence that diabetes was associated with lower wages or
earnings among certain groups. However, their results were somewhat inconsistent. For example,
Brown et al. (2011) found an earnings penalty for men but not women. Bastida (2002) found an
earnings penalty for women but not men. Minor (2011) concluded that females with type 2
diabetes suffered a wage penalty of nearly 50 percent, by far the largest estimate of how diabetes
affects wages. As Seuring et al. (2015) notes, differences in the populations studied, such as age
groups, likely contribute to some of these different results. Given that diabetes is a progressive
disease, it may affect workers differently as the disease advances. Minor (2013) looked at this in
more detail by examining whether the effect on wages varied base on the number of years since
diagnosis. They found that wages among men decreased 6 to 10 years after being diagnosed.
As diabetes progresses, it appears to contribute to workers exiting the labor force early—and
ultimately can lead to premature deaths. The CDC ranks diabetes among the top 10 causes of
death in the U.S. Vijan et al. (2004) found that individuals who suffered from diabetes lost 0.54
years of life relative to those without diabetes. When considering the economic losses associated
6
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with diabetes, it is important to recognize that the losses are not limited to people living with
diabetes who might work in the absence of the disease. It also includes losses associated with
those who died prematurely due to diabetes. In the absence of the disease, these individuals
might not have died so early and might have continued to work.
Overall, diabetes appears to have a significant negative effect on the labor market, primarily by
reducing employment and increasing premature deaths. The evidence that diabetes reduces
employment appears strong, but the actual size of the effect is not entirely clear. While there is
also evidence to suggest diabetes reduces workers’ earnings, this research is somewhat
inconsistent. The remainder of this section discusses the lost economic activity associated with
diabetes in Kentucky, focusing primarily on the lost reductions in employment and premature
deaths.
Reduced Employment and Earnings Due to Diabetes
As discussed above, individuals with diabetes are less likely to work than the general population.
Data from the Kentucky Behavioral Risk Factors Surveillance System (BRFSS) show that, while
approximately 54 percent of Kentucky’s adult population was employed, only 26 percent of
those with diabetes worked. These differences suggest that a considerably larger share of those
who suffer from diabetes might work and earn an income in the absence of the disease.
Because diabetes is more prevalent among particular groups who may be less likely to work and
earn less income even without diabetes, simply comparing the employment rates for those with
and without diabetes is insufficient. Therefore, logistic regression analysis was used to estimate
the effect of diabetes on employment while accounting for factors such as gender, race,
education, state of residence, and other health conditions that could also affect employment. 1
This type of analysis better isolates the effect of diabetes from these other factors. Figure F
summarizes the estimated effects of diabetes on employment.
The estimates show that diabetes affected employment differently across age and gender. There
were no statistically significant effects on employment for females aged 18 to 44 and males aged
18 to 34. Likewise, diabetes appeared to have little effect on the employment status of older
workers. The negative effects occurred for women between the ages of 45 and 64 and men
between the ages of 35 and 59. For example, diabetes reduced the probability of employment by
10.6 percentage points for men aged 55 to 59. Diabetes had a similar effect on the employment
of women in this age group.
The overall effect of diabetes was somewhat larger for women than men. Diabetes reduced
employment by 4.2 percentage points for adult women and 3.1 percentage points for adult men.
This result differed from the research literature, which typically found a larger adverse effect for
men than women.

1

The regression includes controls for race, gender, age, education, state, and other health conditions. Estimates
shown in Figure F are the marginal effects of diabetes for each group.
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Figure F
Percentage Point Difference in the Probability of Employment
between Those with and without Diabetes
4%
Female
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2%

Male

0%
-2%
-4%
-6%
-6.0%

-5.6%

-8%
-8.8%

-10%
-12%
18-34

35-44

-9.3%
-10.4% -10.6%

45-54

55-59

60-64

65-69

70+

Age Group
Source: CBER analysis of data from the Kentucky Department of Public Health and the United States Centers for
Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2017.
Note: Light red and blue bars show estimates of the marginal effect of diabetes, but were not statistically significant.

Applying these estimates to the number of adult Kentucky residents with diabetes provides an
indication of the total employment losses for the state (Table 1). Diabetes appears to have
reduced employment in Kentucky by 15,700 workers—58 percent, or 9,100, of whom were
women.
In the absence of diabetes, these individuals could potentially earn similar amounts to workers
with comparable characteristics, such as gender, race, and education. The BRFSS records earned
income as ranges, which was insufficient for accurately predicting lost earnings. Therefore, the
Census Bureau’s American Community Survey (ACS) was used to predict lost earnings for
Kentucky residents with diabetes. The first step to estimate these lost wages was to develop a
regression model of annual earnings based on age, gender, race, and education from the ACS.
This model was then used to predict the earnings for Kentucky residents in the BRFSS who had
diabetes. Multiplying these average predicted earnings for each age and gender group by the
number of workers who would be employed in the absence of diabetes provides an estimate of
the lost earnings. Table 1 displays the results of these calculations. The lower levels of
employment that are associated with diabetes reduced earnings in Kentucky by approximately
$551.3 million annually. Assuming a total effective state sales and income tax rate of six percent
suggests that the loss of annual tax revenue totals $33.1 million.
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Table 1
Annual Effect of Diabetes on Employment, Earnings, and Tax Revenues
Kentucky

Age
Group

Number of
Kentucky
Adult
Residents with
Diabetes

18-34
35-44
45-54
55-59
60-64
65-69
70+
Subtotal

11,000
20,200
36,100
27,100
33,100
30,200
59,900
217,600

Effect on Employment
Percentage

Number

Average
Annual Earnings
per Person

Total
Earnings
($millions)

Females
0
0
-8.8
-10.4
-9.3
0
0
-4.2

(3,200)
(2,800)
(3,100)
(9,100)

20,800
25,500
28,300
28,900
24,200
14,200
11,400

(90.6)
(80.9)
(75.0)
(246.5)

(1,300)
(2,100)
(3,200)
(6,600)

30,400
40,000
47,400
47,900
40,100
26,200
20,500

(52.0)
(99.5)
(153.3)
(304.8)

Males
18-34
35-44
45-54
55-59
60-64
65-69
70+
Subtotal

8,600
22,300
38,100
30,300
28,100
32,100
56,700
216,200

0
-6
-5.6
-10.6
0
0
0
-3.1

Total
(15,700)
Potential State Sales & Income Tax Revenue*

(551.32)
(33.08)

* Assumes an effective state sales and income tax rate of 6 percent.
Sources: CBER analysis of data from the Kentucky Department of Public Health and the U.S. Centers for Disease
Control and Prevention Behavioral Risk Factor Surveillance System 2017 and the U.S. Census Bureau, American
Community Survey.

Diabetes-Related Deaths
In 2016, diabetes was listed as a contributing factor to 1,497 deaths in Kentucky (Figure G).
Thirty-three percent of these deaths occurred before the age of 65. In addition to the loss of life,
these deaths during prime working ages represent lost economic activity. Estimates of the lost
earnings can be obtained by examining the amounts these individuals could have earned over a
typical lifetime in the absence of diabetes.
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Figure G
Diabetes-Related Deaths
2000 to 2016
Kentucky
Deaths (65 & Above)
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Source: U.S. Centers for Disease Control and Prevention, WONDER.

The economic losses associated with diabetes-related deaths were estimated based on the
amounts that each person who died might have earned had they been able to live out a natural
life. Others such as Vijan et al. (2004) and the American Diabetes Association (2018) have used
similar methods to estimate lost earnings from premature deaths. This method is based on three
estimates for each decedent given their age and gender: the probability they would be alive; the
probability they would work; and the average income they would earn in each of the following
years had they not died. The probability each person would be alive was calculated from
standard actuarial life tables (United States Social Security Administration, 2005).
Unfortunately, no single data source has the complete information needed to show the amounts
those with diabetes might earn in the absence of the disease. Therefore, multiple data sources
were combined for these estimates.
Disclosure concerns cause the CDC to limit the detail available on the characteristics of
Kentucky residents whose deaths were related to diabetes. For this analysis, age ranges and
gender for each decedent were obtained from the CDC WONDER data system. An approach
similar to the one described earlier was used to estimate the probability of employment and the
average earnings given the age range and gender of each decedent. The ACS, which provides
detailed data on the employment and earnings of respondents living in Kentucky – but does not
indicate whether they had diabetes – was used to develop models of the probability that
individuals work and their earnings if employed. The model accounts for gender, race, age, and
10
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education. The resulting models were applied to data for Kentucky respondents in the BRFSS,
which does indicate whether respondents have diabetes. This provides estimates of the
probability of employment and earnings for each Kentucky respondent with diabetes in the
BRFSS data. These estimates reflect the age, gender, racial characteristics, and educational
attainment of Kentuckians with diabetes. The predicted earnings for each year were multiplied
by the probability of employment and the probability of surviving each year.
Figure H shows examples of the earnings profiles for a 35-year old male and female. The
profiles essentially show the average lifetime earnings lost among individuals with diabetes who
die at the age of 35. The average earnings are low because they include those who do not work
and therefore have no earned income. Average earnings are generally highest during the late 40s
and early 50s. During these ages, individuals are more likely to work and tend to earn their
highest wages. Average earnings tend to fall significantly after the age of 60 when people are
much less likely to work. The average male diabetic who dies at age 35 could have expected to
earn an additional $906,000 of income by the age of 64 in the absence of the disease. Given a
discount rate of four percent, the present value of these lost earnings is $555,000.
Figure H
Profile of Average Annual Earnings
After Age 35
40,000
Female

35,000

Male

Dollars

30,000
25,000
20,000
15,000
10,000
5,000
0
36

40

44

48

52

56
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72

Age
CBER analysis of data from the Kentucky Department of Public Health and the U.S. Centers
for Disease Control and Prevention Behavioral Risk Factor Surveillance System 2017 and the
U.S. Census Bureau, American Community Survey.

Applying the lost future earnings to the number of deaths by age and gender yields estimates of
the lost earning associated with diabetes-related deaths. The estimates exclude deaths over the
age of 64. While they account for a large percentage of deaths, they account for only a small
portion of earnings given the small percentage of people who work past the age of 64.
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Table 2 summarizes the lost earnings. In 2016, there were 473 diabetes-related deaths between
the ages of 35 and 64 in Kentucky. In the absence of diabetes, these individuals could have
expected to earn a total of almost $12 million during the year following their death. Assuming an
effective state income and sales tax rate of six percent suggests that the lost state tax revenue for
this year would be $710,000, or $1,505 per person. The present value of lifetime lost earning was
$100.4 million and the present value of lost state tax revenues would have been over $6 million.
Table 2
Lost Annual Earnings from Diabetes-Related Deaths
Kentucky

Age
Deaths
35 to 39
12
40 to 44
35
45 to 49
55
50 to 54
92
55 to 59
119
60 to 64
160
Total
473
State Tax Revenue

1st-year
Lost Earnings
(millions)
$0.34
0.96
1.68
2.72
3.25
2.91
$11.86
$0.71

Present Value
Lost Earnings
(millions)
$6.66
14.44
19.77
24.98
20.78
13.72
$100.35
$6.02

Note: Excludes diabetes-related deaths over the age of 64. Estimates of state tax revenues are
based on a total effective state sales and income tax rate of six percent.

Three important caveats should be considered when interpreting these estimates. First, the
figures represent losses for deaths that occur in one year. However, the total lost earnings and tax
revenues for any year reflect deaths that have occurred over the past several years. So, the losses
associated with diabetes in any one year would be substantially higher.
Second, the analysis only counted deaths in which diabetes was listed as a contributing factor.
Diabetes contributes to other health issues such as renal failure and cardiovascular disease, but
might not be listed as a cause of death. The American Diabetes Association includes a portion of
deaths from these other diseases when estimating the economic losses from premature deaths.
Because the estimates in Table 2 do not include a portion of these diseases, they may understate
the total losses attributable to diabetes.
Finally, while this study focuses on lost earnings, economists often use the value of a statistical
life (VSL) to measure the losses associated with death. The VSL represents the amount society
would be willing to pay to reduce the number of deaths by one. VSL is often estimated by
examining the additional compensation workers require to take on additional risk. Current
estimates suggest that the VSL is approximately $11 million in the U.S. Value of a life-year
(VLY) is a similar concept that might be more relevant for diabetes-related deaths that often
occur later in life. It refers to the amount society is willing to pay for one additional year of life.
Currently, estimates suggest the VLY is $515,000 (Boardman et al. 2018). Both measures are
considerably larger than the lost earnings.
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Absenteeism
As discussed above, the research provides a wide range of estimates on how diabetes affects the
number of days worked—from no effect to nearly four days lost per year. Given this wide range,
the American Diabetes Association (2018) assumed that diabetes was associated with a reduction
of 1.7 working days for its estimate of the economic losses. Of the nearly 441,000 adults with
diabetes in Kentucky, approximately 123,000 are employed. Although it is not entirely clear how
much they earn, it is assumed that their average wages are $17 per hour. Missing work for 1.7
eight-hour days suggests lost productivity of $231 per year. Lost productivity for all 123,000
workers with diabetes totals over $28 million annually. The extent to which this results in lost
earnings is unclear. Workers and employers may share these costs. Workers who do not receive
paid time off would earn less. Workers who receive paid time off might not see an immediate
decline in their earnings. Employers would initially bear the cost of lower productivity but pass
these costs on to workers in the form of slower wage growth. Assuming the full value of the lost
productivity results in lost earnings suggests that the lost state tax revenues would be $1.7
million annually.
Limitations
While diabetes can reduce employment, the relationships between diabetes and labor market
outcomes are more complicated than diabetes simply reducing employment and earnings. Being
unemployed may contribute to an individual developing diabetes as those without work may find
living a healthy lifestyle to be unaffordable. Additionally, other underlying issues such as a lower
level of motivation or an inability to care for one’s self may contribute to an individual being
both less likely to work and more likely to develop diabetes. This makes it more difficult for
researchers to isolate the degree to which diabetes reduces employment.
One potential limitation of this analysis, and many of the previous studies on this issue, is that it
simply measures the correlation between diabetes and employment rather than the causal impact.
By examining the correlation, even after controlling for factors such as education and other
health conditions, the analysis may over- or under-state the true effects that diabetes has on
employment and earnings. Some researchers have attempted to address this issue by accounting
for genetic markers that signal higher risk of diabetes or a family history of diabetes. The results
are mixed, with some studies finding higher effects, while others find lower effects after attempts
to address these issues. Seuring et al. (2015) suggests that it is not clear how this issue affects the
estimates.
This is an important caveat for policy makers to consider as they evaluate the potential benefits
of programs to address diabetes. Because the analysis addresses the correlation between diabetes
and labor market outcomes rather than isolating the causation, the benefits associated with
policies to reduce the incidence of diabetes are more uncertain.
Section 4: Health Care Costs
Individuals with diabetes generally have significantly higher health care expenditures than the
rest of the population. Data from the Medical Expenditure Panel Survey (MEPS) suggests that
annual national health care spending averaged $13,642 for those with diabetes compared to
$4,991 for those without. However, the higher prevalence of diabetes among older populations,
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along with the other health conditions often associated with diabetes, contributes to this spending
difference.
Every five years, the American Diabetes Association releases a detailed analysis of the economic
cost of diabetes. The association’s analysis includes estimates of the additional health care costs
those with diabetes incur relative to similar individuals without the disease. These estimates,
therefore, account for differences in the prevalence of diabetes across factors such as age,
gender, and race. These figures are often referred to as “excess” health care costs because they
represent costs over the amount an individual without diabetes would typically incur.
Table 4 shows the association’s estimates from 2017 adjusted for medical inflation and regional
differences in health care costs. For example, a 35- to 44-year old with diabetes incurs an
additional $5,074 in health care costs per year relative to a similar person without diabetes.
Applying the ADA’s per capita costs for each age group to the number of Kentucky adults with
diabetes in each age group indicates that diabetes results in approximately $3.9 billion in
additional health care costs to Kentucky annually.
Table 3
Excess Health Care Costs Associated with Diabetes
Kentucky

Age
18 to 34
35 to 44
45 to 54
55 to 59
60 to 64
65 to 69
70 & Over
Total

Cost per
Person
$6,241
5,074
5,963
6,852
6,407
12,065
$12,352

Population with
Diabetes
17,500
28,300
77,300
59,200
60,800
66,200
128,700
438,000

Health Care Costs
(millions)
$109.2
143.6
460.9
405.6
389.6
798.7
1,589.6
$3,897.2

Sources: American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017;
Kentucky Department of Public Health and the U.S. Centers for Disease Control and
Prevention Behavioral Risk Factor Surveillance System 2017.
Notes: Dollars figures are stated in 2018 dollars and adjusted to reflect regional price
differences.

Nationally, the health care expenditures for those with diabetes is largely paid through Medicare.
Table 4 shows the distribution of national health care expenditures for those with and without
diabetes by the source of payment. Medicare pays for 45.4 percent of health care expenditures
for those with diabetes but only 27.4 percent of the expenditures for those without diabetes.
Medicaid pays for approximately 10 percent of the expenditures for those with diabetes.
The Cabinet for Health and Family Services estimated that approximately 168,200 Kentucky
Medicaid recipients had diabetes in 2017. Medicaid expenditures, excluding prescription drugs,
totaled nearly $117 million.
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Table 4
Distribution of Health Care Expenditures
by Source of Payment
United States

Source of Payment
Medicaid
Medicare
Private Insurance
Self-pay
Other
Total

Individuals
with Diabetes
10.3%
45.4
26.6
9.0
8.6
100.0%

Individuals
without Diabetes
9.4%
27.4
42.5
13.5
7.2
100.0%

Source: CBER analysis of Medical Expenditure Panel Survey 2016.

Section 5: Diabetes Prevention and Education Programs
This section examines how two broad programs designed to address diabetes—prevention and
education programs—can affect the lives of their participants. Prevention programs focus on
individuals who are at high-risk of developing diabetes in the future or have been diagnosed with
prediabetes. They are designed to improve participants’ diets and increase their physical activity
to prevent diabetes from developing. Education programs focus on helping those who have
already developed diabetes manage the disease. They also attempt to improve participants’ diets
and physical activity, but they may include components to help participants monitor their glucose
levels or address diabetes-related complications.
The remainder of this section reviews research on the effects of these programs. Because there is
a large volume of research on these programs, the following reviews rely heavily on previous
summaries of the research and meta-analyses. Because prevention and education programs are
diverse, care should be taken in generalizing the results to Kentucky.
Diabetes Prevention Programs
Lifestyle intervention programs appear to be one of the more promising efforts to prevent
diabetes. These programs typically focus on groups who are at high-risk of developing diabetes
or who already exhibit prediabetes. They are designed to reduce the incidence of disease by
helping participants reduce their weight through diet and exercise. The details of lifestyle
interventions and the resources they provide to participants vary considerably across programs.
However, they typically provide educational material and training and may provide continuing
support through case managers and individual or group sessions.
There is a considerable body of research evaluating the effectiveness of lifestyle interventions.
Generally, this research finds that lifestyle interventions can reduce the incidence of diabetes and
improve quality of life among participants. Roberts et al. (2017) provided a meta-analysis of
lifestyle intervention studies across several countries. They found that lifestyle intervention
programs that last for three or more years reduce the incidence of diabetes by 45 percent.
Programs lasting less than three years reduced diabetes by 26 percent. The impact varied across
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programs, ranging from no reduction to a 58 percent reduction in the incidence of diabetes. The
study noted that differences in the intensity and duration of the programs likely contributed to
much of this variation.
The U.S. Diabetes Prevention Program conducted a clinical trial of a lifestyle intervention
program in the U.S. during the late 1990s. Researchers randomly assigned participants to one of
three groups. The first group was able to participate in the lifestyle intervention program. The
second group received metformin, a drug used to control blood sugar in patients with type 2
diabetes. The third group received a placebo. The lifestyle intervention consisted of a 16-session
curriculum that included weekly meetings initially then monthly meetings for approximately
three years. After three years, all participants, regardless of which group they were initially
assigned to, were offered an opportunity to participate in continued follow-up assistance to
encourage weight loss and physical activity.
During the first three years, the lifestyle intervention cost approximately $1,110 to $2,300 per
participant annually. 2 The follow-up assistance cost approximately $140 to $216 per participant
annually. In 2016, the Centers for Medicare & Medicaid Services estimate that similar
prevention program targeted at Medicare recipients would cost approximately $470 per person
during their first year of participation and $188 per person annual to provide maintenance session
(United States. Department of Health and Human Services). 3 The AMA estimates the costs of
diabetes prevention programs range from $400 to $500 per person (American).
During the three-year evaluation period, the incidence of diabetes among the lifestyle
intervention group was 58 percent lower than the placebo group (Knowler et al. 2002). Followup studies showed the lifestyle intervention reduced the incidence of diabetes by 34 percent at 10
years and 27 percent at 15 years (Diabetes Prevention Program Research Group 2015). 4
The Diabetes Prevention Program Research Group (2009) reported that the lifestyle program did
not reduce health care costs sufficiently to cover the intervention costs. However, they concluded
the program was a cost-effective way to improve the lives of those with diabetes. Among health
care programs, cost-effectiveness is often measured by calculating the ratio of additional cost of
the program to the incremental improvement in Quality Adjusted Life Years (QALY). QALYs
represent the number of years that a program or treatment is expected to increase one’s life with
the additional years weighted by the quality of life during those years. For example, a program
that increases life expectancy by two years with a high quality of life during the first year and a
low quality of life during the second year might represent 1.5 QALYs. The lifestyle intervention
yielded an increase of 0.14 QALYs over the placebo. Considering only health care costs, the
cost-effectiveness ratio of the lifestyle program was $16,076 per QALY. However, participants
would likely also incur higher costs such as the value of time spent traveling to and participating

2

Cost stated in 2018 U.S. dollars.
Cost stated in 2018 U.S. dollars.
4
The reduction in incidence may be understated because those in the placebo group were given the option to
participate in lifestyle session after the three-year assessment.
3
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in the program. The cost-effectiveness considering all costs was estimated to be $24,732 per
QALY.
While cost-effectiveness ratios do not provide a clear indication that a program should be
implemented, they provide a method to compare alternative programs. Generally, programs with
lower cost-effectiveness ratios are preferred. Some studies considered a program with a costeffectiveness ratio below $50,000 per QALY as cost-effective. Although this appears to be a
common benchmark, there are some concerns that it might be too low and not reflect the value
people place on improvements in quality of their lives (Neumann et al. 2014).
Li et al. (2010) reviewed the cost-effectiveness of interventions recommended by the American
Diabetes Association to prevent and control diabetes. They concluded that intensive lifestyle
interventions were very cost-effective relative to many of the other interventions recommended
by the association. Only considering costs related to the health care system, they found the
median cost-effectiveness of lifestyle intervention to be $2,074 per QALY. 5 This is lower than
estimates from the U.S. Diabetes Prevention Programs and might reflect differences in the costs
included in the analysis or other differences in the programs. Li et al. (2010) also identified six
other interventions, such as ACEI therapy for intensive hypertension control, which appear to
reduce costs and improve health (see Li et al. (2010) for a complete list).
While this review discusses the potential benefits of lifestyle intervention programs in general, it
will be important for policy makers to consider how these programs would operate in Kentucky.
Much of the research on these programs comes from controlled pilot programs. Often these
programs operate differently when developed for the broader population. Policy makers would
need to consider whether Kentucky might face specific challenges, such as limited access to
exercise and health care facilities in rural areas that could reduce effectiveness.
Potential Effects of Lifestyle Intervention Programs on Earnings
Because lifestyle intervention programs prevent or delay the onset of diabetes, it is reasonable to
expect that they could also improve employment and earnings. While there appears to be no
research examining this relationship, it is possible to illustrate the potential labor market effect
by applying the reductions in incidence to the lifetime earnings of individuals with diabetes in
Kentucky. Figures I, J, and K show how a lifestyle intervention could affect the lifetime earnings
of a 45-year old male with a high risk of developing diabetes.
Figure I shows the expected annual earnings from age 45 through 64 based on data from the
previous analysis of the BRFSS and ACS data. These earnings reflect the probability of being
employed, the average annual earnings for those who are employed, and the probability of being
alive each year.
For example, approximately 60.4 percent of males between the ages of 45 and 54 work, and
those who do earn approximately $47,400 per year. The remaining 39.6 percent of males who do
not work have no earnings. Therefore, the average earnings for a 45-year old male would be
$28,600. The expected earnings at age 46, and each subsequent year, would be somewhat lower
5

Figures were adjusted using the CPI-U.
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to reflect the increased probability of death. Because those with diabetes are less likely to work,
may earn less, and have a greater risk of premature death, their expected earnings each year
would be lower than someone without the disease. Although the effect of diabetes on earnings
was unclear, diabetes was assumed to reduce earnings by 20 percent for this analysis. Those with
diabetes are 1.85 times more likely to die than those without diabetes (Nwaneri et al. 2013). The
probability of surviving each year was adjusted to reflect the higher risk of death for those with
diabetes.
Figure I
Expected Earnings Profile of 45-year Old Male
With and Without Diabetes
$35,000
With Diabetes

Without Diabetes

Annual Earnings

$30,000
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$15,000
$10,000
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Source: CBER analysis of data from the Kentucky Department of Public Health and the U.S. Centers
for Disease Control and Prevention Behavioral Risk Factor Surveillance System 2017 and the U.S.
Census Bureau, American Community Survey.

Figure J shows the incidence rates of diabetes among males who participated in the lifestyle
intervention and those who were in the placebo group from the U.S. Diabetes Prevention
Program (Diabetes Prevention Program Research Group 2015). These rates show that those who
participated in the lifestyle group were considerably less likely to develop diabetes later in life.
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Figure J
Cumulative Incidence of Diabetes among Participants
in the Diabetes Prevention Program
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Source: Diabetes Prevention Program Research Group (2015) Supplemental Material.

Because lifestyle interventions reduce the risk of developing diabetes, they could increase the
likelihood that individuals work and earn a higher wage. Figure K illustrates the potential effect
this could have on the average earnings of participants. The earnings profiles that were shown in
Figure I reflect expected earnings profiles for a 45-year old male with and without diabetes.
However, at age 45, he does not know whether he will develop diabetes, and if so, when. Figure
K addresses this uncertainty by showing the weighted average of these two profiles where the
weights represent the incidence rates of developing diabetes. The incidence rates come from the
DPP study.
The solid grey line in Figure K uses the incidence rates for those assigned to the placebo group in
the DPP study for weights. This line represents the average earnings that a 45-year-old, high-risk
male could expect to earn in the absence of a lifestyle intervention program. The solid black line
is also a weighted average, but the weights reflect the lower incidence of diabetes among those
who participate in the lifestyle intervention. This line represents the average earnings a 45-yearold, high-risk male could expect to earn if he participated in a lifestyle intervention program. The
lower incidence of diabetes among those participating in lifestyle intervention suggests that these
individuals will have a higher probability of working and earning higher wages.
The difference between these earnings shows the potential increase in average earnings that
could result from participating in a lifestyle intervention. A 45-year-old male could expect to
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earn nearly $17,000 more over his career by participating in a lifestyle program. The present
value of these additional earnings is $12,600 using a four percent discount rate. The present
value of the additional state tax revenues is approximately $756. The state would collect these
additional revenues over several years.
While this amount might not cover the cost of participating in a program, it would help offset a
portion of these costs. By reducing the incidence of diabetes, these programs would likely reduce
the losses associated with absenteeism and premature deaths as well.

Figure K
Potential Effect of Lifestyle Intervention Programs on Earnings
of a 45-Year-Old Male with High Risk of Developing Diabetes
$35,000

Difference between black
and gray lines represents the
potential increase in earnings
from intervention.
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Source: CBER analysis of data from the Kentucky Department of Public Health and the U.S. Centers for
Disease Control and Prevention Behavioral Risk Factor Surveillance System 2017; U.S. Census Bureau’s
American Community Survey; and Diabetes Prevention Program Research Group (2015).

Diabetes Education Programs
Education programs are designed to teach those diagnosed with diabetes how to manage their
disease. Evaluation studies have generally found that participants see meaningful improvements
in clinical outcomes such as blood glucose levels, weight, and blood pressure (Chrvala 2016).
However, the few studies that provide estimates of their cost-effectiveness vary substantially,
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ranging from $373 per QALY to nearly $87,000 per QALY. The wide range of estimates makes
it difficult to draw firm conclusions (Lian et al. 2017). 6 Several factors contribute to this range of
estimates.
First, researchers often include different types of costs depending on whether they examine costeffectiveness from the health care system’s perspective or society’s perspective. The health care
system perspective is narrower and often focuses only on the direct health care costs and the
costs to operate the education program. The societal perspective is broader and includes more
costs. Studies that take a societal perspective often include added costs incurred by those
participating in the program, such as the time they spend traveling to and attending sessions, the
added expense of purchasing healthier food, and increased spending on gym memberships or
exercise equipment.
Second, there are significant differences in the scope of services and operations provided by
education programs, which can affect the outcomes. For example, programs with 10 or fewer
hours of contact with participants provided few benefits, but those with more than 10 hours
significantly lowered blood sugar levels (Pillay et al. 2015). Programs also differed in terms of
the type of health care professionals who provided training, how training was delivered (i.e.
individual sessions, group session, or remotely), and the amount of follow-up provided.
Cost-effectiveness measures may also differ based on the timeframe studied. Both Ricci-Cabello
et al. (2014) and Chatterjee et al. (2018) note that there is little information on the long-term
effects of education programs. Two studies simulated the potential long-term effects based on
clinical improvements observed during trial studies. Gillet et al. (2010) estimated that an
education and self-management program implemented in the United Kingdom incurred $9,993 in
additional cost per QALY gained over participants’ lifetimes. 7 Prezio et al. (2014) estimated that
cost per QALY for participants between the ages of 35 and 54 was $143,499 at five years, but
improved to $53,293 at 10 years and $6,187 at 20 years. Their simulations suggest that there may
be long-term savings and improvements in health over the life of participants. Studies that only
include the short-term benefits of the programs may underestimate the cost-effectiveness of
education programs.
The improvements in clinical outcomes associated with education programs might help those
with diabetes remain in the workforce longer and improve their productivity. However, there
appears to be little research on this issue. Cranor et al. (2003) was the only study found that
examined labor market outcomes. The study examined diabetes care programs implemented by
two employer groups. The authors found that the number of sick days used by employees
decreased in one employer group. Unfortunately, the available information was not sufficient to
provide meaningful insight into how education programs might affect employment and earnings
outcomes.
Diabetes education programs appear to have significant potential to help participants manage
their disease. Evaluations show the programs improve clinical outcomes such as blood glucose
6
7

Costs stated in 2018 U.S. dollars.
Costs stated in 2018 U.S. dollars.
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levels, weight, and blood pressure. Currently, there are relatively few studies examining the costeffectiveness of education programs. Those studies that do suggest education programs can be
cost-effective unfortunately provide a wide range of results. A few studies suggest that education
programs might yield cost savings if costs to participants and long-term benefits are included.
Because these studies include participants’ costs such as travel time, their results should not be
interpreted to suggest that government programs would experience fiscal savings. While the
improvements in clinical outcomes might help workers remain in their jobs longer, take fewer
sick days, and earn more, there is currently little information examining these issues.
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